News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Intra-Cellular Therapies (ITCI) Reports Second Quarter 2017 Financial Results And Provides Corporate Update



8/9/2017 12:50:51 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
SharePrint August 09, 2017 08:00 ET | Source: Intra-Cellular Therapies, Inc. NEW YORK, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced its financial results for the second quarter ended June 30, 2017, and provided a corporate update.

Second Quarter 2017 Financial Results

Intra-Cellular Therapies (the Company or ITCI) reported a net loss of $17.8 million, or $0.41 per share (basic and diluted), for the second quarter of 2017 compared to a net loss of $30.8 million, or $0.71 per share (basic and diluted), for the second quarter of 2016.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES